Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice

por Chen, Xin, Liu, Bigang, Li, Qiuhui, Honorio, Sofia, Liu, Xin, Liu, Can, Multani, Asha S., Calhoun-Davis, Tammy, Tang, Dean G.
Publicado 2013

Developing a Novel Two‐Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer

por Zhang, Dingxiao, Lin, Kevin, Lu, Yue, Rycaj, Kiera, Zhong, Yi, Chao, Hsueh‐Ping, Calhoun‐Davis, Tammy, Shen, Jianjun, Tang, Dean G.
Publicado 2016

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

por Jeter, Collene R., Liu, Bigang, Liu, Xin, Chen, Xin, Liu, Can, Calhoun-Davis, Tammy, Repass, John, Zaehres, Holm, Shen, J. J., Tang, Dean G.
Publicado 2011

miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells

por Liu, Ruifang, Liu, Can, Zhang, Dingxiao, Liu, Bigang, Chen, Xin, Rycaj, Kiera, Jeter, Collene, Calhoun-Davis, Tammy, Li, Yandong, Yang, Tao, Wang, Junchen, Tang, Dean G.
Publicado 2016

Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44(+) Cells and Evidence for Epigenetic Mechanisms

por Yan, Hong, Chen, Xin, Zhang, Qiuping, Qin, Jichao, Li, Hangwen, Liu, Can, Calhoun-Davis, Tammy, Coletta, Luis Della, Klostergaard, Jim, Fokt, Izabela, Skora, Stanislaw, Priebe, Waldemar, Bi, Yongyi, Tang, Dean G.
Publicado 2011

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

por Liu, Can, Kelnar, Kevin, Liu, Bigang, Chen, Xin, Calhoun-Davis, Tammy, Li, Hangwen, Patrawala, Lubna, Yan, Hong, Jeter, Collene, Honorio, Sofia, Wiggins, Jason F., Bader, Andreas G., Fagin, Randy, Brown, David, Tang, Dean G.
Publicado 2011

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer

por Zhang, Dingxiao, Park, Daechan, Zhong, Yi, Lu, Yue, Rycaj, Kiera, Gong, Shuai, Chen, Xin, Liu, Xin, Chao, Hsueh-Ping, Whitney, Pamela, Calhoun-Davis, Tammy, Takata, Yoko, Shen, Jianjun, Iyer, Vishwanath R., Tang, Dean G.
Publicado 2016

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis

por Jeter, Collene R, Liu, Bigang, Lu, Yue, Chao, Hsueh-Ping, Zhang, Dingxiao, Liu, Xin, Chen, Xin, Li, Qiuhui, Rycaj, Kiera, Calhoun-Davis, Tammy, Yan, Li, Hu, Qiang, Wang, Jianmin, Shen, Jianjun, Liu, Song, Tang, Dean G
Publicado 2016

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

por Li, Qiuhui, Liu, Bigang, Chao, Hsueh-Ping, Ji, Yibing, Lu, Yue, Mehmood, Rashid, Jeter, Collene, Chen, Taiping, Moore, John R., Li, Wenqian, Liu, Can, Rycaj, Kiera, Tracz, Amanda, Kirk, Jason, Calhoun-Davis, Tammy, Xiong, Jie, Deng, Qu, Huang, Jiaoti, Foster, Barbara A., Gokhale, Abhiram, Chen, Xin, Tang, Dean G.
Publicado 2019

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

por Li, Qiuhui, Liu, Bigang, Chao, Hsueh-Ping, Ji, Yibing, Lu, Yue, Mehmood, Rashid, Jeter, Collene, Chen, Taiping, Moore, John R., Li, Wenqian, Liu, Can, Rycaj, Kiera, Tracz, Amanda, Kirk, Jason, Calhoun-Davis, Tammy, Xiong, Jie, Deng, Qu, Huang, Jiaoti, Foster, Barbara A., Gokhale, Abhiram, Chen, Xin, Tang, Dean G.
Publicado 2020

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

por Li, Qiuhui, Deng, Qu, Chao, Hsueh-Ping, Liu, Xin, Lu, Yue, Lin, Kevin, Liu, Bigang, Tang, Gregory W., Zhang, Dingxiao, Tracz, Amanda, Jeter, Collene, Rycaj, Kiera, Calhoun-Davis, Tammy, Huang, Jiaoti, Rubin, Mark A., Beltran, Himisha, Shen, Jianjun, Chatta, Gurkamal, Puzanov, Igor, Mohler, James L., Wang, Jianmin, Zhao, Ruizhe, Kirk, Jason, Chen, Xin, Tang, Dean G.
Publicado 2018